IRIS - Res&Arch Institutional Research Information System - Research & Archive

LUCIDI, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.672
EU - Europa 2.287
AS - Asia 2.195
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 191
AF - Africa 56
OC - Oceania 19
Totale 8.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.582
SG - Singapore 1.078
IE - Irlanda 336
CN - Cina 332
IT - Italia 323
RU - Federazione Russa 307
UA - Ucraina 304
BR - Brasile 245
HK - Hong Kong 235
SE - Svezia 219
FR - Francia 199
DE - Germania 178
VN - Vietnam 172
FI - Finlandia 131
GB - Regno Unito 107
BD - Bangladesh 78
IN - India 64
TR - Turchia 46
KR - Corea 45
CA - Canada 43
AT - Austria 31
AR - Argentina 29
PL - Polonia 28
ES - Italia 27
MX - Messico 27
ZA - Sudafrica 23
IQ - Iraq 19
JP - Giappone 18
AU - Australia 17
NL - Olanda 17
CO - Colombia 14
UZ - Uzbekistan 14
ID - Indonesia 13
VE - Venezuela 13
BE - Belgio 12
CH - Svizzera 11
PK - Pakistan 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
EC - Ecuador 10
PH - Filippine 10
RO - Romania 8
GR - Grecia 7
KE - Kenya 7
LB - Libano 7
MA - Marocco 6
NP - Nepal 6
PE - Perù 6
BO - Bolivia 5
CL - Cile 5
DK - Danimarca 5
RS - Serbia 5
AL - Albania 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
OM - Oman 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
EE - Estonia 3
KZ - Kazakistan 3
LT - Lituania 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
PY - Paraguay 2
SR - Suriname 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MU - Mauritius 1
Totale 8.557
Salva come PNG Salva come JPEG
Città #
Singapore 775
Chandler 375
Dublin 336
San Jose 328
Ashburn 234
Hong Kong 232
San Mateo 197
Jacksonville 175
Boardman 142
Santa Clara 130
Altamura 110
Moscow 99
Medford 97
Princeton 95
Wilmington 89
Lauterbourg 84
New York 84
Beijing 83
Los Angeles 80
Perugia 80
Ann Arbor 74
Lawrence 73
Munich 63
Dong Ket 57
Seoul 44
Helsinki 43
Andover 39
Ho Chi Minh City 39
Brooklyn 28
Des Moines 28
Chicago 26
Saint Petersburg 26
Dallas 25
Rome 25
São Paulo 22
The Dalles 22
Woodbridge 21
Denver 20
Piscataway 20
Atlanta 19
Izmir 19
Warsaw 19
Hanoi 18
Norwalk 18
Orem 18
Vienna 18
Amelia 17
Frankfurt am Main 17
Fremont 17
Tokyo 16
Montreal 15
Nuremberg 15
Turku 15
Shanghai 14
Valencia 14
Stockholm 13
Brussels 11
Houston 11
Phoenix 11
San Francisco 11
Amsterdam 10
Ankara 10
Buffalo 10
Falkenstein 10
Falls Church 10
Milan 10
San Paolo di Civitate 10
Tashkent 10
Toronto 10
London 9
Poplar 9
Belo Horizonte 8
Chennai 8
Johannesburg 8
Manchester 8
Redwood City 8
Bexley 7
Haiphong 7
Istanbul 7
Melbourne 7
Mexico City 7
Redmond 7
San Diego 7
Athens 6
Baghdad 6
Cardiff 6
Da Nang 6
Hyderabad 6
Juárez 6
Renton 6
Belgrade 5
Bolton 5
Boston 5
Brno 5
Bucu 5
Buenos Aires 5
Lausanne 5
Mumbai 5
Nairobi 5
Pittsburgh 5
Totale 5.135
Salva come PNG Salva come JPEG
Nome #
Ethanol impairs post-prandial hepatic protein metabolism 297
Administration of Recombinant Human GH on Alternate Days is sufficient to increase whole Body Protein Synthesis and Lipolysis in GH Deficient Adults 288
Hypoglycemia 155
Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes 154
18. Insulin required for prandial ghrelin suppression in humans 137
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia. 136
Alternative indicators of metabolic control 129
Portal vein glucose sensors do not play a major role in modulating physiological responses to insulin-induced hypoglycemia in humans. 129
Circulating palmitoleic acid is an independent determinant of insulin sensitivity, beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal analysis 129
A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults 128
A novel surrogate index for hepatic insulin resistance. 127
Liver protein synthesis in physiology and in disease states 126
Pharmacokinetics and pharmacodynamic of therapeutic dose of basel insulins NPH, Glargine and Detemir after one week of daily administration at bedtime in Type 2 daibates: a randomized, cross-over study. 121
Comparison of pharmacokinetics and-dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes mellitus: a double-blind, randomized, cross-over study. 120
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules. 120
Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. 118
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes mellitus. 116
Ipoglicemia: implicazioni cliniche e impatto sulla salute 115
Contribution of amino acids and insulin to protein anabolism during meal absorption. 114
Short-term effects of the long-acting insulin analog detemir and human insulin on plasma levels of insulin-like growth factor-I and its binding proteins in humans. 113
Insulin is required for prandial ghrelin suppression in humans 111
Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. 110
Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study. 109
Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange 108
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 107
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study 104
Fasting insulin has a stronger association with an adverse cardiometabolic risk profile than insulin resistance: the RISC study. 103
A randomized controlled trial to evaluate the efficacy of ultrasound-guided laser photocoagulation for treatment of benign thyroid nodules 102
Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in Type 2 diabetes. 102
Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis. 98
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. 98
Body composition and common carotid artery remodeling in a healthy population 96
Termoablazione laser percutanea quale alternativa all’intervento di tiroidectomia totale nei pazienti ad alto rischio operatorio 95
Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus 95
PHARMACOKINETIC AND PHARMACODYNAMIC HEAD-TO-HEAD COMPARISON OF CLINICAL, EQUIVALENT DOSES OF INSULIN GLARGINE 300 U/ML AND INSULIN DEGLUDEC 100 U/ML IN TYPE 1 DIABETES 95
Metabolism of insulin glargine after repeated daily subcutaneous injections in subjects with type 2 diabetes. 94
Pharmacokinetics, pharmacodynamics, and modulation of hepatic glucose production with insulin glargine U300 and glargine U100 at steady state with individualized clinical doses in type 1 diabetes 93
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial 92
SHORT-TERM TREATMENT WITH LOW DOSES OF RECOMBINANT HUMAN GROWTH HORMONE (GH) STIMULATES LIPOLYSIS IN VISCERAL OBESE MEN 92
Chloroquine reduces whole body proteolysis in humans 90
Effects of dietary protein restriction on albumin and fibrinogen synthesis in macroalbuminuric type 2 diabetic patients. 90
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 88
Ricoveri per ipoglicemia grave in soggetti con diabete mellito di tipo 2: impatto clinico e costi sanitari 88
Insulin sensitivity and carotid intima-media thickness: relationship between insulin sensitivity and cardiovascular risk study. 85
One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort 85
Dietary protein intake does not affect IgG synthesis in patients with nephrotic syndrome. 84
Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. 84
L’ipoglicemia silente nella pratica clinica quotidiana: come diagnosticarla, gestirla e prevenirla 84
Obesity and carotid artery remodeling 84
Increased albumin and fibrinogen synthesis in hemodialysis patients with normal nutritional status 83
Physical inactivity is the main cause of the metabolic syndrome 83
Circulatin ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement 83
Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes. 83
Pharmacokinetics and pharmacodynamics of NPH insulin in type 1 diabetes: The Importance of appropriate resuspension before subcutaneous injection 83
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: A dose–response study 82
Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure 81
Diurnal Cycling of Insulin Sensitivity in Type 2 Diabetes: Evidence for Deviation From Physiology at an Early Stage 77
Effect of sedentary behaviour and vigorous physical activity on segment-specific carotid wall thickness and its progression in a healthy population 76
Low levels of unmodified insulin glargine in plasma of people with type 2 diabetes requiring high doses of basal insulin 74
Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. 73
Circulating ghrelin levels of visceral obese men are not modified by a short-term treatment with very low doses of GH replacement. 72
Effects of dietary protein restriction on fibrinogen and albumin metabolism in nephrotic patients 71
The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women 71
Moderate and large doses of ethanol differentially affect hepatic protein metabolism in humans 69
Optimizing the replacement of basal insulin in Type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. 69
Gamma-glutamyltransferase, arterial remodeling and prehypertension in a healthy population at low cardiometabolic risk 69
Tecniche Nefrologiche e dialitiche 67
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. 66
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes. 66
How to accurately establish pharmacokinetics/ pharmacodynamics of long- Acting insulins in humans: Relevance to biosimilar insulins 64
Prevention and Management of Severe Hypoglycemia and Hypoglycemia Unawareness: Incorporating Sensor Technology 64
The physiological basis of insulin therapy in people with diabetes mellitus 64
Effects of whole-body vibration exercise on the endocrine system of healthy men. 63
INSULIN SENSITIVITY IN TYPE 2 DIABETIC PATIENTS IS DIFFERENT BETWEEN GLUCOSE AND PROTEIN METABOLISM 63
Metabolic and endocrine effects of physiological increments in plasma ghrelin concentrations 62
Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia 62
Impact of family history on relations between insulin resistance, LDL cholesterol and carotid IMT in healthy adults 61
Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations 61
Treatment of growth hormone deficiency syndrome in adults 60
Metabolic effects of an SGLT2 inhibitor (Dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes. Diabetes care 2020;43:2128– 2136 60
Nicotinamide counteracts alcohol-induced impairment of hepatic protein metabolism in humans 59
Gender differences in basal protein kinetics in young adults 59
Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials 59
Real-time continuous glucose monitoring decreases the risk of severe hypoglycemia in people with type 1 diabetes and impaired awareness of hypoglycemia 58
Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by Type 2 diabetic subjects. 58
The role of gastric emptying in glucose homeostasis and defense against hypoglycemia: Innocent bystander or partner in crime? 57
Plasma ghrelin concentrations, food intake, and anorexia in liver failure 56
From Metabolic Normality to Cardiometabolic Risk Factors in Subjects With Obesity 54
Insulin sensitivity and beta-cell function in the offspring of type 2 diabetic patients: impact of line of inheritance. 53
Meal intake similarly reduces circulating concentrations of octanoyl and total ghrelin in humans 53
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population 51
Ethanol impairs post-prandial hepatic protein metabolism. 50
Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. 49
Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration 49
One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs 49
GLP-1 RAs as compared to prandial insulin after failure of basal insulin in type 2 diabetes: Lessons from the 4B and Get-Goal DUO 2 trials 47
Glucose Control in Diabetes: Targets and Therapy 43
An overview of randomized clinical trials of fixed‐ratio combinations of basal insulin plus GLP ‐ 1RA (injectable therapy): Lessons for advancing therapy in people with type 2 diabetes 15
The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes 14
Totale 8.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 0 0 21 38 18 9 8 230 7 18 99 107
2022/20231.243 98 259 17 88 88 157 0 58 441 1 28 8
2023/2024517 34 49 28 7 2 11 100 0 54 26 103 103
2024/20251.306 10 123 31 78 201 41 38 107 290 93 166 128
2025/20262.895 217 182 153 268 409 213 544 138 376 203 114 78
2026/2027645 355 228 62 0 0 0 0 0 0 0 0 0
Totale 8.753